New FDA Opioid Guide Adds Abuse Risks to Approval Deliberation

June 26, 2019

Drugmakers developing new opioid painkillers would have to highlight the drug’s risks as part of its approval process under new guidance the Food and Drug Administration (FDA) proposed on June 20.

Related Stories